Results 201 to 210 of about 3,376,621 (386)

RESPONSE: Re: Adherence to Therapy With Oral Antineoplastic Agents [PDF]

, 2002
Ann H. Partridge
openalex   +1 more source

Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor‐Stroma Co‐Culture Model

Advanced Healthcare Materials, EarlyView.
This research introduces a cold plasma‐based platform for treating breast cancer bone metastases. Using a novel bioprinted 3D tumor‐stroma model, it highlights the selective antitumor effects of plasma‐generated reactive species. The platform aims to advance non‐invasive therapeutic strategies, offering potential clinical applications in controlling ...
Laura M. Bouret, Jean‐Baptiste Billeau, Michael H. Weber, Derek H. Rosenzweig, Stephan Reuter   +4 more
wiley   +1 more source

Rituximab synergizes with hydroxyurea or vincristine in the killing of Ramos Burkitt's lymphoma B cell line [PDF]

, 2014
Abulayha, Abdulmunem, Bredan, Amin, Deyab, Mohamed, Elbanani, Abdulrhman, Geriani, Hajer, Lamami, Yosra, Tabal, Salah   +6 more
core   +2 more sources

Protein Kinase C Activity in Human Leukemia Cell Lines with Reference to Sensitivity to Antineoplastic Agents.

, 1992
Shunichi Sugawara, Nobuko Kumano, Yasuo Saijo, Shuji Suzuki, Yuka Numata, George Sato, Masakichi Motomiya   +6 more
openalex   +2 more sources

Antineoplastic Agents. 515. Synthesis of Human Cancer Cell Growth Inhibitors Derived from 3,4-Methylenedioxy-5,4‘-dimethoxy-3‘-amino-Z-stilbene [PDF]

, 2005
George R. Pettit, Collin R. Anderson, Eric J. Gapud, M. Katherine Jung, John Knight, Ernest Hamel, Robin K. Pettit   +6 more
openalex   +1 more source

Advanced Oral Delivery Systems for Nutraceuticals

Advanced Healthcare Materials, EarlyView.
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang, Linzixuan Zhang, Zhiling Zheng, Robert Langer, Ana Jaklenec   +4 more
wiley   +1 more source

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital. [PDF]

Front Public Health, 2022
Villanueva-Bueno C, Collado-Borrell R, Escudero-Vilaplana V, Revuelta-Herrero JL, Marzal-Alfaro MB, González-Haba E, Arranz-Arija JÁ, Osorio S, Herranz-Alonso A, Sanjurjo-Saez M.   +9 more
europepmc   +1 more source

Antineoplastic Agents. 545. Isolation and Structure of Turbostatins 1−4 from the Asian Marine MolluskTurbo stenogyrus^,1 [PDF]

, 2005
George R. Pettit, Yuping Tang, John Knight   +2 more
openalex   +1 more source

RBC Membrane‐Camouflaged Nanosystem‐Mediated Synergistic Drug Combination for Enhanced Anti‐Tumor Therapy

Advanced Healthcare Materials, EarlyView.
An RBC membrane camouflaged, cell‐penetrating peptides R8‐based drug delivery system is constructed to achieve a synergistic combination of natural compounds triptolide (TP) and celastrol (Cel), inducing tumor cell apoptosis, reducing tumor metastasis invasion and triggering autophagy disorder in breast cancer and liver cancer.
Qian Cheng, Xuemei Zhong, Lu Deng, Xinling He, Miaoxizi Luo, Ruibing Wang, Jinming Zhang   +6 more
wiley   +1 more source

Navigating Stomatologic Complications Secondary to Antineoplastic Agents-A Comprehensive Review. [PDF]

Cancers (Basel)
Popovici IA, Kajanto LA, Popovici LR, Augustin IG, Gales LN.   +4 more
europepmc   +1 more source